Passer au contenu principal

Jean Roy

Jean Roy

Docteur

Affiliation

Université de Montréal

Research Axes

Clinical research

Contact information

jean.roy.1@umontreal.ca

A hematologist specializing in hematopoietic stem cell transplantation, Dr. Jean Roy has been the Maryse and William Brock Chair in Applied Research into Stem Cell Transplantation at Université de Montréal since 2016. A clinical researcher who is very involved in his field, Dr. Roy has published over 60 papers and presented 200 abstracts at provincial, national and international conferences. He regularly serves as a scientific advisor and reviewer and teaches as a full professor in the Department of Medicine in the Faculty of Medicine at Université de Montréal.

Research Unit

Dr. Jean Roy is a member of the Hematopoietic Stem Cell Transplant Clinical Research Unit. He is particularly interested in multiple myeloma and allogeneic transplantation to cure this disease. His projects aim to make allogeneic transplantation more effective and less toxic for patients, for example, through the use of myeloma drugs post-transplantation or the use of cord cells expanded with UM171 to achieve a more potent antimyeloma effect.

  • Ahmad I, LeBlanc R, Cohen S, Lachance S, Kiss T, Sauvageau G, Roy DC, Busque L, Delisle JS, Bambace N, Bernard L and Roy J. Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation. Bone Marrow Transplantation 2016;51;529-535.
  • Sandra Cohen, Jean Roy, Silvy Lachance, Jean-Sébastien Delisle, Anne Marinier, Lambert Busque, Denis Claude Roy, Frédéric Barabé, Imran Ahmad, Nadia Bambace, Léa Bernard, Thomas Kiss, Philippe Bouchard, Pierre Caudrelier, Séverine Landais, Fannie Larochelle, Jalila Chagraoui, Bernhard Lehnertz, Sophie Corneau, Elisa Tomellini, Jeroen J.A. van Kampen, Jan J. Cornelissen, Maude Dumont-Lagacé, Mégane Tanguay, Qi Li, Sébastien Lemieux, Peter W. Zandstra, Guy Sauvageau. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study. Lancet Haematology 2020;7:134-145.
  • Richard LeBlanc, Jean-Sébastien Claveau, Imran Ahmad, Séverine Landais, Nadia Bambace, Léa Bernard, Sandra Cohen, Jean-Sébastien Delisle, Thomas Kiss, Silvy Lachance, Guy Sauvageau, Denis Claude Roy and Jean Roy. Newly diagnosed multiple myeloma patients treated with tandem auto-allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only. Clinical Transplantation 2020. doi: 10.1111/ctr.14099.
    More detail

Education

  • Fellow in internal medicine and hematology

    Royal College of Physicians and Surgeons of Canada (FRCPC)

  • Fellowship in hematopoietic stem cell transplantation and clinical research

    University of Minnesota, Minneapolis, Minnesota

  • Residency in hematology

    McGill University

  • Residency in internal medicine

    Université Laval and McGill University

  • Doctor of Medicine

    Université Laval, Québec

Awards

  • 2017 Award for scientific excellence  (Collège des médecins du Québec)